Jasper Therapeutics (JSPR) Shares Issued (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Shares Issued of $417231.0 for Q4 2025, up 809.12% year-over-year from $45894.0 in Q4 2024, and down 42.21% quarter-over-quarter from $721955.0 in Q3 2025.
Jasper Therapeutics (JSPR) Shares Issued (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Shares Issued history runs 6 years deep, the most recent figure standing at $417231.0 for Q4 2025.
- In Q4 2025, Shares Issued rose 809.12% year-over-year to $417231.0; the TTM figure through Dec 2025 stood at $417231.0 (up 809.12% YoY), while the FY2025 annual figure was $417231.0, up 809.12% from the prior year.
- Shares Issued for Q4 2025 stood at $417231.0, down from $721955.0 in the prior quarter.
- The five-year high for Shares Issued was $5.9 million in Q1 2022, with the low at $20000.0 in Q2 2024.
- The 5-year median for Shares Issued is $498367.5 (2023), against an average of $1.2 million.
- The sharpest annual moves came in 2023 and 2025: Shares Issued slumped 96.57% in 2023, then soared 2321.68% in 2025.
- Jasper Therapeutics' Shares Issued stood at $46394.0 in 2021, then changed by 0.0% to $46394.0 in 2022, then surged by 2143.56% to $1.0 million in 2023, then slumped by 95.59% to $45894.0 in 2024, then jumped by 809.12% to $417231.0 in 2025.
- Business Quant data shows JSPR's Shares Issued at $417231.0 in Q4 2025, $721955.0 in Q3 2025, and $484335.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 417,231.00 |
| Dec 31, 2025 | 417,231.00 |
| Sep 30, 2025 | 721,955.00 |
| Sep 30, 2025 | 721,955.00 |
| Jun 30, 2025 | 484,335.00 |
| Jun 30, 2025 | 484,335.00 |
| Mar 31, 2025 | 499,426.00 |
| Mar 31, 2025 | 499,426.00 |
| Dec 31, 2024 | 45,894.00 |
| Dec 31, 2024 | 45,894.00 |
| Sep 30, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 81,885.00 |
| Mar 31, 2024 | 81,885.00 |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |